Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|July 4, 2012
Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902Young Hak Kim, Masataka Hirabayashi, Yosuke Togashi, et al.
Anticancer Research|January 10, 2014
Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancerAkito Hata, Nobuyuki Katakami, Kosuke Tanaka, et al.
Thoracic Cancer|December 17, 2025
Salvage Surgery Following Systemic Therapy in Initially Unresectable Non-Small Cell Lung CancerKatsutoshi Seto, Yoshitsugu Horio, Katsuhiro Masago, et al.
Cancer Genetics|March 23, 2025
Immune prognostic model for glioblastoma based on the ssGSEA enrichment scoreTakanari Okamoto, Ryo Mizuta, Ayako Demachi-Okamura, et al.
The Journal of Pathology|May 3, 2025
Clinicopathological and molecular characterization of KRAS wild-type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genesKazuhiro Toriyama, Katsuhiro Masago, Noriko Shibata, et al.
Molecular and Clinical Oncology|April 29, 2014
Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patientsJumpei Takeshita, Katsuhiro Masago, Shiro Fujita, et al.
Cancer Genetics|March 11, 2025
Biological landscape of human papilloma virus-related head and neck cancer according to virus genotypeKatsuhiro Masago, Hiromasa Ishihara, Hiroaki Kuroda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel TestingMasashi Mikubo, Katsutoshi Seto, Atsuko Kitamura, et al.
Translational Lung Cancer Research|October 24, 2025
The difference in tumor immune microenvironment and IFN-γ response between solid and non-solid adenocarcinomaShuichi Shinohara, Daisuke Muraoka, Ayako Demachi-Okamura, et al.
Anticancer Research|February 11, 2015
Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastasesAkito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, et al.
Pageof 13